Polymeric Nanoparticles—Tools in a Drug Delivery System in Selected Cancer Therapies
Source abstract
Abstract
The increase in cancer cases is undoubtedly affecting the development of new therapeutic approaches. Polymeric nanoparticles are of great interest. Due to their relatively small size, the possibility of incorporating into them medicinal substances and the ease with which their physicochemical properties may be manipulated, they are being used as anticancer drug delivery systems. The aim of this review is to focus on the use of nanoscale polymeric particles in the treatment of colorectal cancer, breast cancer, ovarian cancer and glioblastoma multiforme, and to consider their potential use in cancer gene therapy. According to several reports, the use of polymer nanoparticles as drug carriers is promising in solid tumors. With their application, it is possible to precisely deliver medicinal substances to the tumor structure, to overcome the blood–brain barrier in the case of brain tumors, to reduce the side effects of anticancer agents on normal cells and to achieve a therapeutic effect with a lower drug dose. Additionally, a number of reports indicate that they can also be used in combination with other methods of cancer treatment, mainly radiotherapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055 Katowice, Poland
References (100+)
Show source-provided references
1. Drug-loaded polymeric nanoparticles for cancer stem cell targeting
2. Niculescu, A.G., and Grumezescu, A.M. (2022). Novel tumor-targeting nanoparticles for cancer treatment-a review. Int. J. Mol. Sci., 23.10.3390/ijms23095253 ↗
3. Sartaj, A., Qamar, Z., Qizilbash, F.F., Annu, M.S., Alhakamy, N.A., Baboota, S., and Ali, J. (2021). Polymeric nanoparticles: Exploring the current drug development and therapeutic insight of breast cancer treatment and recommendations. Polymers., 13.10.3390/polym13244400 ↗
4. Emerging trends in colorectal cancer: Dysregulated signaling pathways (review)10.3892/ijmm.2021.4847 ↗
5. Mahmoud, B.S., AlAmri, A.H., and McConville, C. (2020). Polymeric nanoparticles for the treatment of malignant gliomas. Cancers, 12.10.3390/cancers12010175 ↗
6. Biodegradable polymeric nanoparticles for drug delivery to solid tumors10.3389/fphar.2021.601626 ↗
7. Zielińska, A., Carreiró, F., Oliveira, A.M., Neves, A., Pires, B., Venkatesh, D.N., Durazzo, A., Lucarini, M., Eder, P., and Silva, A.M. (2020). Polymeric nanoparticles: Production, characterization, toxicology and ecotoxicology. Molecules, 25.10.3390/molecules25163731 ↗
8. Advanced polymeric nanoagents for oral cancer theranostics: A mini review10.3389/fchem.2022.927595 ↗
9. Polymeric nanoparticles for cancer therapy10.1080/10611860701794353 ↗
10. Pulingam, T., Foroozandeh, P., Chuah, J.A., and Sudesh, K. (2022). Exploring various techniques for the chemical and biological synthesis of polymeric nanoparticles. Nanomaterials, 12.10.3390/nano12030576 ↗
11. Rai, R., Alwani, S., and Badea, I. (2019). Polymeric nanoparticles in gene therapy: New avenues of design and optimization for delivery applications. Polymers, 11.10.3390/polym11040745 ↗
12. Cruz-Nova, P., Ancira-Cortez, A., Ferro-Flores, G., Ocampo-García, B., and Gibbens-Bandala, B. (2022). Controlled-release nanosystems with a dual function of targeted therapy and radiotherapy in colorectal cancer. Pharmaceutics, 14.10.3390/pharmaceutics14051095 ↗
13. The importance of nanoparticle shape in cancer drug delivery10.1517/17425247.2014.950564 ↗
14. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles10.1016/j.ijpharm.2005.11.040 ↗
15. Niza, E., Ocaña, A., Castro-Osma, J.A., Bravo, I., and Alonso-Moreno, C. (2021). Polyester polymeric nanoparticles as platforms in the development of novel nanomedicines for cancer treatment. Cancers, 13.10.3390/cancers13143387 ↗
16. Curcuminoid-loaded poly(methyl methacrylate) nanoparticles for cancer therapy10.2147/IJN.S124021 ↗
17. Intelligent biosynthetic nanobiomaterials (IBNs) for hyperthermic gene delivery10.1007/s11095-007-9382-5 ↗
18. Chemotherapy: A double-edged sword in cancer treatment10.1007/s00262-021-03013-3 ↗
19. Nanoparticle-based drug delivery systems for cancer therapy10.1016/j.smaim.2020.04.001 ↗
20. Control of polymeric nanoparticle size to improve therapeutic delivery10.1016/j.jconrel.2015.10.006 ↗
21. Kaps, A., Gwiazdoń, P., and Chodurek, E. (2021). Nanoformulations for delivery of pentacyclic triterpenoids in anticancer therapies. Molecules, 26.10.3390/molecules26061764 ↗
22. Nanoparticles for cancer therapy: Current progress and challenges10.1186/s11671-021-03628-6 ↗
23. Biodegradable polymeric nanoparticles for therapeutic cancer treatments10.1146/annurev-chembioeng-060817-084055 ↗
24. Polymeric nanoparticles: A study on the preparation variables and characterization methods10.1016/j.msec.2017.06.004 ↗
25. Neerooa, B.N.H.M., Ooi, L.T., Shameli, K., Dahlan, N.A., Islam, J.M.M., Pushpamalar, J., and Teow, S.Y. (2021). Development of polymer-assisted nanoparticles and nanogels for cancer therapy: An update. Gels, 7.10.3390/gels7020060 ↗
26. PLGA-based nanoparticles in cancer treatment10.3389/fphar.2018.01260 ↗
27. Gad, A., Kydd, J., Piel, B., and Rai, P. (2016). Targeting cancer using polymeric nanoparticle mediated combination chemotherapy. Int J Nanomed. Nanosurg., 2.10.16966/2470-3206.116 ↗
28. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells10.3109/03639045.2011.641562 ↗
29. Chakravarty, P., Famili, A., Nagapudi, K., and Al-Sayah, M.A. (2019). Using supercritical fluid technology as a green alternative during the preparation of drug delivery systems. Pharmaceutics, 11.10.3390/pharmaceutics11120629 ↗
30. Celecoxib nanoparticles for therapeutic angiogenesis10.1021/acsnano.5b04137 ↗
31. Interplay between solid tumors and tumor microenvironment10.3389/fimmu.2022.882718 ↗
32. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy10.1016/j.ejpb.2015.03.018 ↗
33. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?10.1016/j.jconrel.2016.11.015 ↗
34. Ejigah, V., Owoseni, O., Bataille-Backer, P., Ogundipe, O.D., Fisusi, F.A., and Adesina, S.K. (2022). Approaches to improve macromolecule and nanoparticle accumulation in the tumor microenvironment by the enhanced permeability and retention effect. Polymers, 14.10.3390/polym14132601 ↗
35. New challenges in the use of nanomedicine in cancer therapy10.1080/21655979.2021.2012907 ↗
36. Naki, T., and Aderibigbe, B.A. (2022). Efficacy of polymer-based nanomedicine for the treatment of brain cancer. Pharmaceutics, 14.10.3390/pharmaceutics14051048 ↗
37. Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles10.3109/02652048.2015.1035683 ↗
38. Malki, A., ElRuz, R.A., Gupta, I., Allouch, A., Vranic, S., and Al Moustafa, A.E. (2020). Molecular mechanisms of colon cancer progression and metastasis: Recent Insights and Advancements. Int. J. Mol. Sci., 22.10.3390/ijms22010130 ↗
39. Al-Joufi, F.A., Setia, A., Salem-Bekhit, M.M., Sahu, R.K., Alqahtani, F.Y., Widyowati, R., and Aleanizy, F.S. (2022). Molecular pathogenesis of colorectal cancer with an emphasis on recent advances in biomarkers, as well as nanotechnology-based diagnostic and therapeutic approaches. Nanomaterials, 12.10.3390/nano12010169 ↗
40. Aleksandrova, K., Reichmann, R., Kaaks, R., Jenab, M., Bueno-de-Mesquita, H.B., Dahm, C.C., Eriksen, A.K., Tjønneland, A., Artaud, F., and Boutron-Ruault, M.C. (2021). Development and validation of a lifestyle-based model for colorectal cancer risk prediction: The LiFeCRC score. BMC Med., 19.10.1186/s12916-020-01826-0 ↗
41. Wang, K., Shen, R., Meng, T., Hu, F., and Yuan, H. (2022). Nano-drug delivery systems based on different targeting mechanisms in the targeted therapy of colorectal cancer. Molecules, 27.10.3390/molecules27092981 ↗
42. Orally administrable therapeutic nanoparticles for the treatment of colorectal cancer10.3389/fbioe.2021.670124 ↗
43. Wu, P., Zhou, Q., Zhu, H., Zhuang, Y., and Bao, J. (2020). Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-fluorouracil and perfluorocarbon. BMC Cancer, 20.10.1186/s12885-020-06803-7 ↗
44. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer10.1080/10837450.2019.1684945 ↗
45. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-fluorouracil and chrysin10.1080/09205063.2020.1743946 ↗
46. Alshaman, R., Alattar, A., El-Sayed, R.M., Gardouh, A.R., Elshaer, R.E., Elkazaz, A.Y., Eladl, M.A., El-Sherbiny, M., Farag, N.E., and Hamdan, A.M. (2022). Formulation and characterization of doxycycline-loaded polymeric nanoparticles for testing antitumor/antiangiogenic action in experimental colon cancer in mice. Nanomaterials, 12.10.3390/nano12050857 ↗
47. Factorial design formulation optimization and in vitro characterization of curcumin-loaded PLGA nanoparticles for colon delivery10.1016/j.jddst.2016.01.007 ↗
48. SN-38 active loading in poly(lactic-co-glycolic acid) nanoparticles and assessment of their anticancer properties on COLO-205 human colon adenocarcinoma cells10.3109/02652048.2015.1081416 ↗
49. Development of a novel nanoformulation against the colorectal cancer10.1016/j.lfs.2021.119772 ↗
50. Fabrication and characterization of chitosan-based polymeric nanoparticles of imatinib for colorectal cancer targeting application10.1016/j.ijbiomac.2020.02.151 ↗
51. Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer10.1016/j.msec.2020.111678 ↗
52. Co-delivery of quercetin and caffeic-acid phenethyl ester by polymeric nanoparticles for improved antitumor efficacy in colon cancer cells10.1080/02652048.2021.1948623 ↗
53. Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells10.1039/D0BM00556H ↗
54. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy10.1016/j.colsurfb.2019.02.031 ↗
55. Dos Santos-Silva, A.M., de Caland, L.B., do Nascimento, E.G., Oliveira, A.L.C.S.L., de Araújo-Júnior, R.F., Cornélio, A.M., Fernandes-Pedrosa, M.F., and da Silva-Júnior, A.A. (2019). Self-assembled benznidazole-loaded cationic nanoparticles containing cholesterol/sialic acid: Physicochemical properties, in vitro drug release and in vitro anticancer efficacy. Int. J. Mol. Sci., 20.10.3390/ijms20092350 ↗
56. PEGylated-paclitaxel and dihydroartemisinin nanoparticles for simultaneously delivering paclitaxel and dihydroartemisinin to colorectal cancer10.1007/s11095-020-02819-7 ↗
57. A convergent synthetic platform for polymeric nanoparticle for the treatment of combination colorectal cancer therapy10.1080/09205063.2021.1941556 ↗
58. Co-administration of iRGD enhances tumor-targeted delivery and anti-tumor effects of paclitaxel-loaded PLGA nanoparticles for colorectal cancer treatment10.2147/IJN.S219820 ↗
59. Polymer-based nanoparticles for chemo/gene-therapy: Evaluation its therapeutic efficacy and toxicity against colorectal carcinoma10.1016/j.biopha.2019.109257 ↗
60. Nanoparticles in colorectal cancer therapy: Latest in vivo assays, clinical trials, and patents10.1208/s12249-020-01731-y ↗
61. Fraguas-Sánchez, A.I., Lozza, I., and Torres-Suárez, A.I. (2022). Actively targeted nanomedicines in breast cancer: From pre-clinal investigation to clinic. Cancers, 14.10.3390/cancers14051198 ↗
62. Major advancements in metastatic breast cancer treatment: When expanding options means prolonging survival10.1016/j.esmoop.2022.100409 ↗
63. Global increase in breast cancer incidence: Risk factors and preventive measures10.1155/2022/9605439 ↗
64. Huang, J., Chan, W.C., Ngai, C.H., Lok, V., Zhang, L., Lucero-Prisno, D.E., Xu, W., Zheng, Z.J., Elcarte, E., and Withers, M. (2022). On Behalf Of Ncd Global Health Research Group Of Association Of Pacific Rim Universities Apru. worldwide burden, risk factors, and temporal trends of ovarian cancer: A global study. Cancers, 14.10.3390/cancers14092230 ↗
65. Akter, S., Rahman, M.A., Hasan, M.N., Akhter, H., Noor, P., Islam, R., Shin, Y., Rahman, M.D.H., Gazi, M.S., and Huda, M.N. (2022). Recent advances in ovarian cancer: Therapeutic strategies, potential biomarkers, and technological improvements. Cells, 11.10.3390/cells11040650 ↗
66. Olaparib and paclitaxel in combination with carboplatin in treatment of ovarian cancer: Influence on disease control
67. Ahmed, M.M., Anwer, M.K., Fatima, F., Aldawsari, M.F., Alalaiwe, A., Alali, A.S., Alharthi, A.I., and Kalam, M.A. (2022). Boosting the anticancer activity of sunitinib malate in breast cancer through lipid polymer hybrid nanoparticles approach. Polymers, 14.10.3390/polym14122459 ↗
68. Jurczyk, M., Kasperczyk, J., Wrześniok, D., Beberok, A., and Jelonek, K. (2022). Nanoparticles loaded with docetaxel and resveratrol as an advanced tool for cancer therapy. Biomedicines, 10.10.3390/biomedicines10051187 ↗
69. In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cells10.1186/s12645-019-0048-x ↗
70. Manipulation of the nanoscale presentation of integrin ligand produces cancer cells with enhanced stemness and robust tumorigenicity10.1021/acs.nanolett.1c00501 ↗
71. Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors10.1016/j.ajps.2018.03.002 ↗
72. Fabrication and in vitro evaluation of magnetic PLGA nanoparticles as a potential methotrexate delivery system for breast cancer10.1016/j.jddst.2018.01.002 ↗
73. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth10.1186/1757-2215-3-11 ↗
74. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer
75. Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy10.1016/j.jconrel.2014.12.043 ↗
76. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: Formulation, characterization, and targeted drug delivery10.1080/10717544.2022.2058645 ↗
77. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells10.1016/j.jconrel.2014.11.011 ↗
78. A combinational approach towards treatment of breast cancer: An analysis of noscapine-loaded polymeric nanoparticles and doxorubicin10.1208/s12249-020-01710-3 ↗
79. Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy10.1016/j.ijpharm.2020.119875 ↗
80. Delivery of apoptosis-inducing piperine to triple-negative breast cancer cells via co-polymeric nanoparticles10.21873/anticanres.13998 ↗
81. Tumor-targeting polycaprolactone nanoparticles with codelivery of paclitaxel and IR780 for combinational therapy of drug-resistant ovarian cancer10.1021/acsbiomaterials.0c00163 ↗
82. Alassaif, F.R., Alassaif, E.R., Kaushik, A.K., and Dhanapal, J. (2022). Enhanced anti-proliferative effect of carboplatin in ovarian cancer cells exploiting chitosan-poly (lactic glycolic acid) nanoparticles. Recent Pat. Nanotechnol.
83. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: In vitro and in vivo10.1186/s13046-018-0700-z ↗
84. Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer10.4155/fdd-2019-0005 ↗
85. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer10.1016/j.jconrel.2013.07.014 ↗
86. Preparation of colloidal nanoparticles PVA-PHEMA from hydrolysis of copolymers of PVAc-PHEMA as anticancer drug carriers10.1088/1361-6528/ac6089 ↗
87. Hydroxyapatite-poly(vinyl alcohol) core-shell nanoparticles for dual delivery of methotrexate and gemcitabine for bone cancer treatment10.1016/j.jddst.2019.03.041 ↗
88. Combined therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology10.7150/thno.40298 ↗
89. Kurowska, N., Strzalka-Mrozik, B., Madej, M., Pająk, K., Kruszniewska-Rajs, C., Kaspera, W., and Gola, J.M. (2022). Differences in the expression patterns of TGFβ isoforms and associated genes in astrocytic brain tumors. Cancers, 14.10.3390/cancers14081876 ↗
90. Designing biodegradable wafers based on poly(L-lactide-co-glycolide) and poly(glycolide-co-ε-caprolactone) for the prolonged and local release of idarubicin for the therapy of glioblastoma multiforme10.1007/s11095-020-02810-2 ↗
91. Rajaratnam, V., Islam, M.M., Yang, M., Slaby, R., Ramirez, H.M., and Mirza, S.P. (2020). Glioblastoma: Pathogenesis and current status of chemotherapy and other novel treatments. Cancers, 12.10.3390/cancers12040937 ↗
92. Caraway, C.A., Gaitsch, H., Wicks, E.E., Kalluri, A., Kunadi, N., and Tyler, B.M. (2022). Polymeric nanoparticles in brain cancer therapy: A review of current approaches. Polymers, 14.10.3390/polym14142963 ↗
93. Poly(p-phenylenevinylene) nanoparticles modified with antiEGFRvIII for specific glioblastoma therapy10.1038/s41598-021-83931-5 ↗
94. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line10.1016/j.pdpdt.2018.06.026 ↗
95. Effect of paclitaxel/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma10.1016/j.ijpharm.2021.120722 ↗
96. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation10.1016/j.lfs.2020.117943 ↗
97. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: In vitro and in vivo evaluation10.1016/j.ijpharm.2011.08.052 ↗
98. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells10.18632/oncotarget.7896 ↗
99. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy10.2147/IJN.S167142 ↗
100. Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development10.1016/j.ijpharm.2019.118733 ↗